The caesar salad at Siena Restaurants in Rhode Island gets rave reviews. But its significance goes much deeper, to the heart of family, the heartbreak of grieving, and the hope that can come from the love that’s left behind. Here, Siena Restaurants co-owner Chef Anthony Tarro shares the story of his father’s famous caesar salad recipe and the meaning it had for his family, his father’s experience with Alzheimer’s disease, and how he and his family continue to fight back against the disease in his name, even after his passing.
You can help in the fight against Alzheimer’s too. Here’s how >
Groundbreaking Alzheimer’s Study Administers First Dose
The first infusion of an investigational drug that aims to delay or help to prevent the earliest memory loss due to Alzheimer’s disease took place in September at Butler Hospital in Providence, R.I., researchers announced.
Passion for Fitness Fuels Sam Slezak’s Leadership in National Study to Protect Brain Health
Sam Slezak originally set out to become a trainer for professional athletes. Here’s how and why he became a project manager for a landmark national Alzheimer’s study instead.
Dr. Hwamee Oh Awarded NIH Grant for Study of Neuroimaging Markers of Early Alzheimer’s
The study seeks to identify new cognitive and neural biomarkers of preclinical Alzheimer’s disease, which would aid in earlier diagnosis and interventional treatment for the disease.
Katie Brandt Shares 5 Critical Dementia Caregiving Tips
Caregiver to both her young husband and her father with dementia, now she’s supporting others in the caregiver journey.
Butler Hospital among first in U.S. to launch new study of promising Alzheimer’s treatment
AHEAD 3-45 is a clinical trial for a treatment aimed at preventing cognitive decline in people with preclinical Alzheimer’s Disease (AD).
The Fight Against Alzheimer’s Continues Amid Coronavirus
MAP Director Dr. Stephen Salloway, along with other international leaders in the fight against Alzheimer’s, talk with the Providence Journal and WJAR NBC10 about how the fight to end Alzheimer’s continues despite coronavirus.
Drug studied at Butler Hospital could become first to meaningfully change course of Alzheimer’s
Aducanumab, an investigational drug for the treatment for Alzheimer’s disease, has been submitted to the FDA for approval with a request for Priority Review. If approved, it would become the first therapy to reduce the clinical decline of Alzheimer’s disease.
RI Chosen as 1 of 5 Sites for First Nationwide Study of Lifestyle Intervention to Reduce Risk of Cognitive Decline
The U.S. Study to Protect Brain Health Through Lifestyle Intervention to Reduce Risk (U.S. POINTER) is sponsored by the Alzheimer’s Association and is the first such study to be conducted in a large, diverse group of Americans across the United States.
Can smartphone technology detect preclinical Alzheimer’s? New study aims to find out.
Louisa Thompson, Ph.D., research scientist at Brown University and Butler Hospital, will evaluate how app-based and online cognitive tests might be used to detect subtle changes in memory and thinking associated with Alzheimer’s.